囊性纤维化患者分离出的丝状真菌对两性霉素B、伊曲康唑和咪康唑的体外敏感性
In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosis.
作者信息
Hennequin C, Benailly N, Silly C, Sorin M, Scheinmann P, Lenoir G, Gaillard J L, Berche P
机构信息
Laboratoire de Parasitologie, Service de Microbiologie, Hôpital Necker-Enfants Malades, Paris, France.
出版信息
Antimicrob Agents Chemother. 1997 Sep;41(9):2064-6. doi: 10.1128/AAC.41.9.2064.
Abstract
The antimicrobial activities of amphotericin B, itraconazole, and miconazole against 101 filamentous fungi from patients with cystic fibrosis were tested by a reproducible microdilution method. Itraconazole was very active against Aspergillus species and Scedosporium species (MIC at which 90% of the isolates were inhibited [MIC90], 0.06 to 0.5 mg/liter), whereas amphotericin B was less effective (MIC90, 0.5 to 8 mg/liter).
摘要
采用可重复的微量稀释法，对两性霉素B、伊曲康唑和咪康唑针对101株来自囊性纤维化患者的丝状真菌的抗菌活性进行了测试。伊曲康唑对曲霉菌属和赛多孢属非常有效（90%分离株被抑制时的最低抑菌浓度[MIC90]，0.06至0.5毫克/升），而两性霉素B的效果较差（MIC90，0.5至8毫克/升）。
相似文献
1
In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosis.囊性纤维化患者分离出的丝状真菌对两性霉素B、伊曲康唑和咪康唑的体外敏感性
Antimicrob Agents Chemother. 1997 Sep;41(9):2064-6. doi: 10.1128/AAC.41.9.2064.
2
Antifungal activity of amphotericin B and itraconazole against filamentous fungi: comparison of the Sensititre Yeast One and NCCLS M38--a reference methods.两性霉素B和伊曲康唑对丝状真菌的抗真菌活性：Sensititre Yeast One与NCCLS M38参考方法的比较
J Chemother. 2004 Oct;16(5):468-73. doi: 10.1179/joc.2004.16.5.468.
3
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.通过肉汤微量稀释法增加致病丝状真菌接种量对抗真菌剂最低抑菌浓度的影响。
J Clin Microbiol. 1995 May;33(5):1302-7. doi: 10.1128/jcm.33.5.1302-1307.1995.
4
In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species.特比萘芬、伊曲康唑和两性霉素B对曲霉菌和枝孢菌属的体外活性。
J Chemother. 2002 Dec;14(6):562-7. doi: 10.1179/joc.2002.14.6.562.
5
In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole.曲霉属菌株对两性霉素B和伊曲康唑的体外敏感性
J Antimicrob Chemother. 1999 Oct;44(4):553-5. doi: 10.1093/jac/44.4.553.
6
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.伏立康唑、两性霉素B和伊曲康唑对192株丝状真菌的体外活性（MIC和MFC）：GISIA-2研究
J Chemother. 2007 Oct;19(5):508-13. doi: 10.1179/joc.2007.19.5.508.
7
Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.pH对两性霉素B、伊曲康唑和氟胞嘧啶体外抗曲霉菌分离株活性的影响。
Antimicrob Agents Chemother. 2004 Aug;48(8):3147-50. doi: 10.1128/AAC.48.8.3147-3150.2004.
8
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.伏立康唑、伊曲康唑和两性霉素B对丝状真菌的体外活性。
J Antimicrob Chemother. 1998 Dec;42(6):741-5. doi: 10.1093/jac/42.6.741.
9
Fungal infection of cystic fibrosis patients - single center experience.囊性纤维化患者的真菌感染——单中心经验
Pneumonol Alergol Pol. 2016;84(3):151-9. doi: 10.5603/PiAP.2016.0017.
10
In vitro susceptibility of Trichosporon beigelii to antifungal agents.白吉利丝孢酵母对抗真菌药物的体外敏感性
J Chemother. 1996 Dec;8(6):445-8. doi: 10.1179/joc.1996.8.6.445.
引用本文的文献
1
Ecology of Scedosporium Species: Present Knowledge and Future Research.棘孢木霉属的生态学：现有知识和未来研究。
Mycopathologia. 2018 Feb;183(1):185-200. doi: 10.1007/s11046-017-0200-2. Epub 2017 Sep 19.
2
Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis.对囊性纤维化患者分离出的阿氏丝孢霉进行基因分型研究。
J Clin Microbiol. 2002 Jun;40(6):2108-14. doi: 10.1128/JCM.40.6.2108-2114.2002.
3
Sputum itraconazole concentrations in cystic fibrosis patients.囊性纤维化患者痰液中的伊曲康唑浓度。
Antimicrob Agents Chemother. 2001 Jun;45(6):1937-8. doi: 10.1128/AAC.45.6.1937-1938.2001.
本文引用的文献
1
Antifungal susceptibility testing: technical advances and potential clinical applications.抗真菌药敏试验：技术进展与潜在临床应用
Clin Infect Dis. 1997 May;24(5):776-84. doi: 10.1093/clinids/24.5.776.
2
Allergic bronchopulmonary mycosis caused by Pseudallescheria boydii.由博伊德假阿利什菌引起的变应性支气管肺真菌病。
Am Rev Respir Dis. 1993 Sep;148(3):810-2. doi: 10.1164/ajrccm/148.3.810.
3
Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.囊性纤维化患者的变应性支气管肺曲霉病
Chest. 1994 Jan;105(1):32-6. doi: 10.1378/chest.105.1.32.
4
Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis.一名患有囊性纤维化和变应性支气管肺曲霉病的患者发生播散性曲霉病。
Pediatr Pulmonol. 1994 Feb;17(2):131-4. doi: 10.1002/ppul.1950170210.
5
Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis.
Lancet. 1993 Feb 20;341(8843):492. doi: 10.1016/0140-6736(93)90244-b.
6
Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.丝状真菌抗真菌药敏试验标准化的比较与协作评估
Antimicrob Agents Chemother. 1995 Feb;39(2):314-9. doi: 10.1128/AAC.39.2.314.
7
Invasive aspergillosis after bilateral lung transplantation in cystic fibrosis.
Respir Med. 1995 Jul;89(6):449-51. doi: 10.1016/0954-6111(95)90216-3.
8
Treatment of invasive aspergillosis with itraconazole.伊曲康唑治疗侵袭性曲霉病
Am J Med. 1989 Jun;86(6 Pt 2):791-800. doi: 10.1016/0002-9343(89)90475-0.
9
Microbiology of airway disease in patients with cystic fibrosis.囊性纤维化患者气道疾病的微生物学
Clin Microbiol Rev. 1991 Jan;4(1):35-51. doi: 10.1128/CMR.4.1.35.
10
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.伊曲康唑对变应性支气管肺曲霉病的辅助治疗
Chest. 1991 Sep;100(3):813-9. doi: 10.1378/chest.100.3.813.
Zotero 插件